30 Jul Ascend Advanced Therapies
Ascend Advanced Therapies (Ascend) is a specialist adeno-associated virus (AAV) development partner working to bring next-generation gene therapy products to market. Carrying forward from therapeutic development, Ascend hit the ground running via operational facilities globally. With AAV roots going back to 1991, the experienced team offers unparalleled insight and collaboration when delivering products from gene to GMP. A flexible platform supports all AAV serotypes across scales with proprietary and partnered technologies and a world-class analytical toolkit. GMP manufacturing capacity was added in 2024 via the acquisition of Beacon Therapeutics, enabling the team to Aim Higher in balancing yield and quality of commercially accessible life-saving therapies.
